AI Isn't the Problem—Fragmentation Is

Everyone is racing to add AI to healthcare.

But what if the bigger problem isn't adopting AI… it's the fragmented systems underneath it?

In this episode of Med Tech Gurus, we sit down with Nader Fathi, serial entrepreneur and CEO of Enlil, to explore why the future of MedTech innovation may depend less on adding more intelligence—and more on creating integrated foundations that allow innovation to scale.

With decades of experience spanning AI, big data, IoT, and regulated product development, Nader makes a compelling case that many MedTech companies are solving the wrong problem. While others rush toward AI tools, he argues the real risk is fragmentation across compliance, engineering, quality systems, and manufacturing—creating hidden vulnerabilities that slow innovation and threaten scale.

We explore why integrated compliance is becoming a strategic advantage, how private AI models and agentic AI may reshape product development, and why "customers, customers, customers" remains timeless advice for founders building scalable companies.

From FDA readiness and change control to product-market fit and investor storytelling, this episode is a masterclass in moving from product innovation to enterprise execution.

If you're interested in AI in healthcare, MedTech quality systems, regulatory strategy, SaaS for medical devices, or startup scale-up strategy, this episode delivers a powerful blueprint for building innovation that lasts.